Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MEXC Launches MEXC Global Card With Up to 10% Cashback and 7% Annualized Returns
-
Nano Labs Announces Resignation of Director
-
HCWC Announces Host Digital Secures $1.25 Billion, 15-Year AI Data Center Lease
-
Blossom Gold Commences Drilling Program on the Kamma Claims, West of the Rosebud Open-Pit, Heap Leach Project
-
KBR Awarded FEED Contract for Live Oak Consortium’s Large-Scale e-NG Project in Nebraska
-
FirstCash Upsizes and Extends Term of Unsecured Bank Credit Facility; Size of Committed Facility Increased from $700 Million to $1.1 Billion; Maturity Date Extended to August 2031
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
26th China International Fair for Investment and Trade to be held in Xiamen, Sept. 8-11; guest countries of honor debut
-
Transactions in connection with share buyback programme
-
Medera Presents Late-Breaking Clinical Trial Data at ESC Congress 2026 Demonstrating Durable Improvement in HFpEF Cardiac Filling Pressures Following SRD-002 Gene Therapy
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Result of the auction of treasury bills on 31 august 2026
-
WEBUY GLOBAL LTD. Reports Record NATAS Fair Bookings of US$ 4.76 Million, 42% Higher than March 2026
-
Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations
-
Changes in the Management Board of Harju Elekter’s Swedish subsidiary
-
Transactions in connection with share buyback programme
-
Festi hf.: Transactions in relation to a share repurchase programme - week 35
-
Asprofin Bank Corporation Expands Into Embedded Finance as Caribbean Offshore Banking Enters the API Era
-
WeRide Included in HKEX Tech 100 Index Following September 2026 Quarterly Review
-
Martin Frandsen Tobberup appointed CEO of the company operating BEAM
-
XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation
-
Danske Bank share buy-back programme: transactions in week 35
-
Creative Capital Announces Sponsorship of Ukrainian World Champion OptiWay Sailing Team
-
AL Sydbank A/S share buyback programme: transactions in week 35
-
Preliminary data on early redemptions (prepayments)
-
Notice on Concluded Lease Agreement
-
Bull Selected to Deliver Europe’s €387.8 Million LUMI-AI Supercomputer in Finland
-
Octave and MAIRE collaborate on the application of AI across engineering and construction workflows
-
Share buyback programme – week 35
-
52/2026・Trifork Group: Weekly report on share buyback
-
VyOS Announces Technology Partnership with Defguard to Support Open, Identity-Aware Remote Access
-
Prepayments, Realkredit Danmark A/S
-
Unaudited information of Invalda INVL group for 6 months of 2026
-
FLSmidth: Transactions under share buy-back programme
-
Impact of acquisitions: Civinity grew by a third over the past 12 months
-
Aktsiaselts Infortar signed an agreement to sell shareholding in its subsidiaries
-
AkzoNobel and Axalta announce three directors to finalize Board of combined company
-
Major Shareholder Announcement
-
Share Buy-back Programme – Transactions Week 35
-
Share repurchase programme: Transactions of week 35 2026
-
Sampo plc did not acquire its own shares during week 35/2026
-
LexinFintech Holdings Ltd. Reports Second Quarter 2026 Unaudited Financial Results
-
Start of Day Message
-
Aktsiaselts Infortar own share acquisition transactions
-
DEKUPLE GROUP CONTINUES TO ROLL OUT ITS AMBITION 2030 STRATEGIC ROADMAP AND DELIVERS SOLID GROWTH IN THE FIRST HALF OF 2026
-
Decisive Showdown in Barcelona: OMODA 4 Makes Its European Debut as CYBER MECHA Takes Center Stage at VCT EMEA
-
Momcozy Publishes a First-Year Guide to Everyday Baby Care and Safety
-
Leios Therapeutics Announces Exclusive Licensing Agreement and Strategic Investment with Subsidiaries of China Medical System Holdings Ltd. for 10XB-101
-
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer i
-
Mutual Benefits Agreement with Birch Narrows Dene Nation
